Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Phenylephrine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Phenylephrine hydrochloride
Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

What it is and what it is used for

for 2. What you need to know before you take Max strength congestion relief capsules 3. How to take Max strength congestion relief capsules 4. Possible side effects 5. How to store Max Strength Congestion Relief capsules 6. Contents of the pack and other information 1. What Max strength congestion relief capsules are and what they are used for Your capsules contain the active ingredient, phenylephrine hydrochloride, a decongestant that reduces swelling in the passages of the nose to help you breathe more easily. Your capsules are used for the relief of nasal congestion, particularly when associated with colds and flu or hayfever.

What you need to know before you take it

e Max strength congestion relief capsules Do not take this medicine if you:

  • are allergic to phenylephrine or any of the other ingredients
  • have a serious heart condition or cardiovascular disorder(s)
  • have high blood pressure (hypertension)
  • have diabetes
  • have glaucoma
  • have an overactive thyroid (hyperthyroidism)
  • have an enlarged prostate or other prostate problems
  • have phaeochromocytoma (a rare tumour of adrenal gland tissue)
  • are taking antidepressant drugs called monoamine oxidase inhibitors (MAOIs), or have taken them within the last 14 days –

these are medicines such as phenelzine and isocarboxazid

  • are taking other decongestant medicines
  • are pregnant or breastfeeding. Please see your doctor or pharmacist before taking this medicine if you:
  • have circulatory problems such as Raynaud's Phenomenon
  • have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. If you are taking any of the following medicines, please see your doctor or pharmacist:
  • tricyclic antidepressants such as imipramine and amitriptyline
  • decongestant drugs or stimulants (e.g. ephedrine, amphetamines and xylometazoline)
  • Medicines to lower blood pressure, treat heart or circulatory problems such as beta blockers, vasodilators (e.g. hydralazine), cardiac glycosides (e.g. digoxin). Other Important Information: Do not drink alcohol (beer, wine, spirits etc.) while taking this product. Information about some of the ingredients in this medicine

This medicine contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

How to take it

Max strength congestion relief capsules

Google Play or Apple App Store. By reporting side affects you can help provide more information on the safety of this medicine.

Warning: Do not exceed the stated dose. Avoid alcohol whilst taking this medicine. If you take too many capsules by mistake, contact your doctor or pharmacist straight away. If symptoms persist or worsen, or if new symptoms occur, consult your doctor or pharmacist.

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow This leaflet was last revised in 09/2025. MPLLPHE12.2CP012 Card Scheme at: www.mhra.gov.uk/yellowcard FPLXXX392V01_A GSL or search for MHRA Yellow Card in the

Flamingo Max Strength Congestion Relief 12.2 mg Capsules, Hard

28 mm

Package Leaflet: Information for the user

5 mm

28 mm

140 mm

Back Page

How to store it

Max strength congestion relief capsules

Keep out of the sight and reach of children. Do not use these capsules after the expiry For oral use, swallow whole with water. date mentioned on the blisters and carton. Adults, the elderly and children 12 years Do not store above 25°C. Store in the original and over : 1 capsule every 6 hours, as required. packaging to protect from moisture. Do not take more than 4 capsules in any 24 Do not throw away any medicines via hour period. wastewater or household waste. Not recommended for children under 12 Ask your pharmacist how to throw away years of age. Do not take for longer than 7 days unless you medicines you no longer use. These measures will help protect the environment. have been advised to do so by your doctor.

4. Possible side effects

Each capsule contains 12.2mg of Phenylephrine Hydrochloride. The other ingredients are lactose monohydrate maize starch, pregelatinised starch, magnesium stearate. Capsule shells are made of gelatin, iron oxide yellow and sodium laurilsulfate. What Max strength congestion relief capsules looks like and contents of the pack Size "3" hard gelatin capsule, yellow translucent cap & body, containing white to off-white granular powder or powder plug.

Most people do not have any side effects while taking this medicine. However, if you experience any of the following side effects, or anything else unusual happens, stop taking the medicine immediately and see your doctor Max strength congestion relief capsules are or pharmacist. available in cartons containing AluminiumPVC/PVDC White Opaque Film blister packs Possible side effects are: of 12 Capsules.

  • fast heart rate
  • changes in heart rhythm Marketing Authorization Holder
  • palpitations Flamingo Pharma (UK) Ltd.
  • high blood pressure 1st Floor, Kirkland House,
  • nausea 11-15 Peterborough Road,
  • vomiting Harrow, Middlesex,
  • headache HA1 2AX, United Kingdom.
  • difficulty passing water (the frequency is Manufacturer unknown but is more likely to occur in men Flamingo Pharma (UK) Limited with an enlarged prostate). The Bloc, 38 Springfield Way, Reporting of side effects Anlaby, Hull, HU10 6RJ, United Kingdom. If you get any side effects, talk to your doctor, Product licence number pharmacist or nurse. This includes any possible PL 43461/0125

Frequently asked questions about Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard

How do I take Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard?

Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard comes as capsule containing 12.2mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard?

The active substance in Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard is phenylephrine hydrochloride.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Phenylephrine hydrochloride (60 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For the relief of nasal congestion, particularly when associated with colds and flu or hayfever.

4.2. Posology and method of administration

Adults and children 12 years and over: For oral use, one capsule, if necessary, up to four times daily.

The Elderly: Normal adult dosage is appropriate.

Children under 12 years: Not recommended.

4.3. Contraindications

Hypersensitivity to any of the ingredients. Avoid in patients with cardiovascular disease, hypertension, diabetes mellitus, closed angle glaucoma, hyperthyroidism, prostatic enlargement and phaeochromocytoma. Patients being treated with monoamine oxidase inhibitors or within 14 days of ceasing such treatment (see section 4.5).

4.4. Special warnings and precautions for use

This medicine should be used with caution in patients with occlusive vascular disease including Raynaud's phenomenon. Do not take for longer than 7 days, unless your doctor agrees.

This medicine contains 40.3 mg Lactose Monohydrate. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.

If symptoms do not go away seek a doctor's advice.

Use with caution in patients with Raynaud's phenomenon and diabetes mellitus.

Patients with prostatic hypertrophy may have increased difficulty with micturition.

Sympathomimetic-containing products should be used with great care in patients suffering from angina.

Sympathomimetic-containing products may act as cerebral stimulants giving rise to insomnia, nervousness, and hyperpyrexia, tremor and epileptiform convulsions.

4.5. Interaction with other medicinal products and other forms of interaction

Should not be given to patients being treated with monoamine oxidase inhibitors or within 14 days of stopping such treatment. May enhance the effects of anticholinergic drugs such as tricyclic antidepressants. May increase the possibility of arrhythmias in digitalised patients. May enhance the cardiovascular effects of other sympathomimetic amines (e.g. decongestants). This medicine should not be taken together with vasodilators, Beta-blockers or enzyme inducers such as alcohol.

4.6. Fertility, pregnancy and lactation

The safety of this medicine during pregnancy and lactation has not been established but in view of a possible association of foetal abnormalities with first trimester exposure to phenylephrine, the use of the product during pregnancy should be avoided. In addition, because phenylephrine may reduce placental perfusion, the product should not be used in patients with a history of pre-eclampsia. In view of the lack of data on the use of phenylephrine during lactation, this medicine should not be used during breast feeding

4.7. Effects on ability to drive and use machines

No adverse effects known.

4.8. Undesirable effects

Adverse effects may include tachycardia, cardiac arrhythmias, palpitations, hypertension, nausea, vomiting and headache. Urinary retention - this is more likely to occur in men with an enlarged prostate' (frequency not known).

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Symptoms of over dosage include irritability, restlessness, palpitations, hypertension, and difficulty in micturition, nausea, vomiting, thirst and convulsions. In severe over dosage gastric lavage and aspiration should be performed. Symptomatic and supportive measures should be undertaken, particularly with regard to cardiovascular and respiratory systems. Convulsions should be controlled with intravenous diazepam. Chlorpromazine may be used to control marked excitement and hallucinations. Severe hypertension may need to be treated with an alpha-adrenoreceptor blocking drug, such as phentolamine. A beta blocker may be required to control cardiac arrhythmias.

🇷🇴 Known in Romania as

Medicines sold in Romania with the same active substance: Cunoscut în România ca

⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.

  • FENEFRIN 100 mg/ml prescriptionPHENYLEPHRINUM · eye / ear / nose
  • FENILEFRINA HYPERICUM 50 micrograme/ml prescriptionPHENYLEPHRINUM · injection / infusion
  • FENILEFRINA AGUETTANT 100 micrograme/ml prescriptionPHENYLEPHRINUM · injection / infusion
  • BIOFLU NAZAL 2,5 mg/ml over the counterPHENYLEPHRINUM · eye / ear / nose
  • BIOFLU NAZAL 5 mg/ml over the counterPHENYLEPHRINUM · eye / ear / nose

Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →

🇵🇱 Known in Poland as

Medicines sold in Poland with the same active substance: W Polsce znany jako

  • OmidriaTrometamolum + Phenylephrini hydrochloridum · taken by mouth

Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →

💬 Ask about this leaflet

Ask anything about Flamingo Max Strength Congestion Relief 12.2 mg capsules, hard. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →